PATENT CLAIM ANALYSIS

Application Number: 15743546
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["546", "153000"]

Abstract:
Compounds that inhibit Myeloid Cell Leukemia-1 (Mcl-1) oncoprotein, and methods of using the same, are provided for treating disease.

Claim (Index 9):
A compound comprising formula (IV): wherein R 41  is a substituent selected from the group consisting of H and optionally substituted alkyl, aryl, and cycloalkyl; Z 41  and Z 42  each can independently represent a substituent selected from the group consisting of H, cyano, OR 42 , COOR 42 , CONR 42 OR 42 , CONR 42 R 42 , CON(R 42 )\u2014S(O) 2 R 42 , and optionally substituted alkyl and aryl;\n each R 42  can independently represent a substituent selected from the group consisting of H and optionally substituted alkyl and aryl; \n A 41  is a bond or a substituent selected from the group consisting of S(\u2550O), S(\u2550O) 2 , and C(\u2550O); \n X 41  is a substituent selected from the group consisting of optionally substituted alkyl, aryl, cycloalkyl, and heterocycloalkyl; and \n pharmaceutically acceptable salts, solvates, hydrates, cocrystals, or prodrugs thereof.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 86.0
- Lexical Diversity: 1.04348
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12104294', '12096393', '14763468', '13823810', '13526337']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7414002646401521
- 35 USC 102 Novelty (BERT): 0.5069004340778411
- Combined Prediction Score: 0.717950281583921
- Mean Citation Score: 268.77087199999994
- Max Citation Score: 276.15472
- Similarity Product: 212.18973537366867

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test